New opportunities of therapeutic hyperthermia (literature review)

Abstract

An electronic search for publications on the results of the use of hyperthermia in medicine was carried out using the Scopus, Web of Science, MedLine, The Cochrane Library, EMBASE, Global Health, CyberLeninka,RSCI, international and regional journals, materials of international congresses, congresses and conferences.

The review analyzes the results of experimental and clinical studies of the therapeutic effect of hyperthermia or in various non-inflammatory diseases. Experimental studies have shown a pronounced damaging effect of hyperthermia on some types of parasites and therapeutic effect on mice genetically predisposed to type 1 and 2 diabetes mellitus. Clinical studies have shown that hyperthermia significantly improves the condition of patients with cardiovascular and pulmonary insufficiency, depressive syndrome, chronic fatigue syndrome, psoriasis, benign prostatic hyperplasia, limb lymphedema, post-radiation fibrosis and Peyronie's disease. It has been shown that the effectiveness of hyperthermia is associated with a wide range of biological and physiological reactions of cells and tissues to heat exposure, including the expression of heat shock proteins. At the same time, the results obtained in an experiment and in a clinic without randomization require further research and confirmation.

Keywords

review / hyperthermia / parasites / diabetes mellitus / cardiovascular and pulmonary failure / psoriasis / depressive syndrome / chronic fatigue syndrome / peripheral arterial disease / benign prostatic hyperplasia / lymphedema / post-radiation fibrosis / Peyronie's disease

References

[1] Fever Therapy. Abstracts and Discussions of papers presented at the First International Conference on Fever Therapy. Ed.: W.M.Simpson, W.Bierman, Ch.M. Carpenter and P.B. Hoeber. New York, 1937. DOI:10.1097/00007611-193806000-00035

[2] Velikov VK, Sheina AN. Pyrotherapy. The Great Medical Encyclopedia. Ed. by B.V. Petrovsky. 3rd ed. Moscow: Soviet Encyclopedia; 1974–1989. Vol. 19. Р. 258–259. (In Russ).

[3] Великов В.К., Шейна А.Н. Пиротерапия. Большая Медицинская Энциклопедия / Под ред. Б.В. Петровский. 3-е изд. Москва: Советская энциклопедия, 1974–1989. Т. 19. С. 258–259.

[4] Kurpeshev OK, van der Zee J. Experimental basis for the use of hyperthermia in oncology. Medical radiology and radiation safety. 2018;63(1):57–77. (In Russ) doi: 10.12737/article_5a8556b4be3e24.36808227

[5] Курпешев О.К., van der Zee J. Экспериментальные основы применения гипертермии в онкологии // Медицинская радиология и радиационная безопасность. 2018. Т. 63, № 1. С. 57–77. doi: 10.12737/article_5a8556b4be3e24.36808227

[6] Suvernev AV, Ivanov GV. Intensive thermotherapy. Novosibirsk: Geo; 2014. 106 p. (In Russ).

[7] Сувернев А.В., Иванов Г.В. Интенсивное теплолечение. Новосибирск: Гео, 2014. 106 с.

[8] Gũllũoğlu BM, Bekrakı A, Çerıkçıoğlu N, Sõyletır G. Immunologic influences of hyperthermia in a rat model of obstructive jaundice. Digestive Diseases and Sciences. 2001;46(11):2378–2384.

[9] Gũllũoğlu B.M., Bekrakı A., Çerıkçıoğlu N., Sõyletır G. Immunologic influences of hyperthermia in a rat model of obstructive jaundice // Digestive Dis Sci. 2001. Vol. 46, N 11. P. 2378–2384.

[10] Pearson J, Low DA, Stöhr E, et al. Hemodynamic responses to heat stress in the resting and exercising human leg: insight into the effect of temperature on skeletal muscle blood flow. Am J Physiol Regul Integr Comp Physiol. 2011;300(3):R663–R673. doi: 10.1152/ajpregu.00662.2010

[11] Pearson J., Low D.A., Stöhr E., et al. Hemodynamic responses to heat stress in the resting and exercising human leg: insight into the effect of temperature on skeletal muscle blood flow // Am J Physiol Regul Integr Comp Physiol. 2011. Vol. 300, N 3. P. R663–R673. doi: 10.1152/ajpregu.00662.2010

[12] Kurpeshev OK. Hyperthermia in the treatment of patients with non-oncological diseases (literature review). Physiotherapy, Balneology and Rehabilitation. 2020;19(6):400–412. (In Russ).

[13] Курпешев О.К. Гипертермия в лечении больных с неонкологическими заболеваниями (обзор литературы) // Физиотерапия, бальнеология и реабилитация. 2020. Т. 19, № 6. С. 400–412.

[14] Grazú V, Silber AM, Moros M, et al. Application of magnetically induced hyperthermia in the model protozoan Crithidia fasciculata as a potential therapy against parasitic infections. Int J Nanomedicine. 2012;7:5351–5360.

[15] Grazú V., Silber A.M., Moros M., et al. Application of magnetically induced hyperthermia in the model protozoan Crithidia fasciculata as a potential therapy against parasitic infections // Int J Nanomedicine. 2012. N 7. P. 5351–5360.

[16] Sazgarnia A, Taheri AR, Soudmand S, et al. Antiparasitic effects of gold nanoparticles with microwave radiation on promastigots and amastigotes of Leishmania major. Int J Hyperthermia. 2013;29(1):79–86. doi: 10.3109/02656736.2012.758875

[17] Sazgarnia A., Taheri A.R., Soudmand S., et al. Antiparasitic effects of gold nanoparticles with microwave radiation on promastigots and amastigotes of Leishmania major // Int J Hyperthermia. 2013. Vol. 29, N 1. P. 79–86. doi: 10.3109/02656736.2012.758875

[18] Raisov TK, Orazalina NM, Kurpeshev OK. Effect of hyperthermia on trichinae viability. The 14th int. sympos. on clinical hyperth. Dubna; 1991. P. 55.

[19] Raisov T.K., Orazalina N.M., Kurpeshev O.K. Effect of hyperthermia on trichinae viability. The 14th int. symposium on clinical hyperthermia. Dubna, 1991. P. 55.

[20] Capitano ML, Ertel BR, Repasky EA, Ostberg JR. Fever-range whole body hyperthermia prevents the onset of type I diabetes in non-obese diabetic mice. Int J Hyperthermia. 2008;24(2):141–149. doi: 10.1080/02656730701858289

[21] Capitano M.L., Ertel B.R., Repasky E.A., Ostberg J.R. Fever-range whole body hyperthermia prevents the onset of type I diabetes in non-obese diabetic mice // Int J Hyperthermia. 2008. Vol. 24, N 2. P. 141–149. doi: 10.1080/02656730701858289

[22] Ueki K, Kondo T, Kahn CR. Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol Cell Biol. 2004;24:5434–5446.

[23] Ueki K., Kondo T., Kahn C.R. Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms // Mol Cell Biol. 2004. Vol. 24. P. 5434–5446.

[24] Sasaki KR, Morino-Koga S, Adachi H, et al. Hyperthermia with mild electrical stimulation protects pancreatic β-cells from cell stresses and apoptosis. Diabetes. 2012;61(4):838–847.

[25] Sasaki K.R., Morino-Koga S., Adachi H., et al. Hyperthermia with mild electrical stimulation protects pancreatic β-cells from cell stresses and apoptosis // Diabetes. 2012. Vol. 61, N 4. P. 838–847.

[26] Kondo T, Motoshima H, Igata M, et al. The role of heat shock response in insulin resistance and diabetes. Diabetes Metab J. 2014;38(2):100–106. doi: 10.4093/dmj.2014.38.2.100

[27] Kondo T., Motoshima H., Igata M., et al. The role of heat shock response in insulin resistance and diabetes // Diabetes Metab J. 2014. Vol. 38, N 2. P. 100–106. doi: 10.4093/dmj.2014.38.2.100

[28] Kokura S, Adachi S, Manabe E, et al. Whole body hyperthermia improves obesity-induced insulin resistance in diabetic mice. Int J Hyperthermia. 2007;23(3):259–265.

[29] Kokura S., Adachi S., Manabe E., et al. Whole body hyperthermia improves obesity-induced insulin resistance in diabetic mice // Int J Hyperthermia. 2007. Vol. 23, N 3. P. 259–265.

[30] Tei C, Imamura T, Kinugawa K, et al. Waon therapy for managing chronic heart failure ― results from a multicenter prospective randomized WAON-CHF study. Circulation J. 2016;80(4):827–834. doi: 10.1253/circj.CJ-16-0051

[31] Tei C., Imamura T., Kinugawa K., et al. Waon therapy for managing chronic heart failure ― results from a multicenter prospective randomized WAON-CHF study // Circulation J. 2016. Vol. 80, N 4. P. 827–834. doi: 10.1253/circj.CJ-16-0051

[32] Kihara T, Miyata M, Fukudome T, et al. Waon therapy improves the prognosis of patients with chronic heart failure. J Cardiol. 2009;53:214–218.

[33] Kihara T., Miyata M., Fukudome T., et al. Waon therapy improves the prognosis of patients with chronic heart failure // J Cardiol. 2009. Vol. 53. P. 214–218.

[34] Tei C, Shinsato T, Miyata M, et al. Waon therapy improves peripheral arterial disease. J Am Coll Cardiol. 2007;50(22):2169–2171. doi: 10.1016/j.jacc.2007.08.025

[35] Tei C., Shinsato T., Miyata M., et al. Waon therapy improves peripheral arterial disease // J Am Coll Cardiol. 2007. Vol. 50, N 22. P. 2169–2171. doi: 10.1016/j.jacc.2007.08.025

[36] Umehara M, Yamaguchi A, et al. Repeated waon therapy improves pulmonary hypertension during exercise in patients with severe chronic obstructive pulmonary disease. J Cardiol. 2008;51(2):106–113. doi: 10.1016/j.jjcc.2008.01.004

[37] Umehara M., Yamaguchi A., Itakura S., et al. Repeated waon therapy improves pulmonary hypertension during exercise in patients with severe chronic obstructive pulmonary disease // J Cardiol. 2008. Vol. 51, N 2. P. 106–113. doi: 10.1016/j.jjcc.2008.01.004

[38] Kikuchi H, Shiozawa N, Takata S, et al. Effect of repeated waon therapy on exercise tolerance and pulmonary function in patients with chronic obstructive pulmonary disease: a pilot controlled clinical trial. Int J COPD. 2014;(9):9–15.

[39] Kikuchi H., Shiozawa N., Takata S., et al. Effect of repeated waon therapy on exercise tolerance and pulmonary function in patients with chronic obstructive pulmonary disease: a pilot controlled clinical trial // Int J COPD. 2014. Vol. 9. P. 9–15.

[40] Rolls ET, Grabenhorst F, Parris BA. Warm pleasant feelings in the brain. Neuroimage. 2008;41(4):1504–1513.

[41] Rolls E.T., Grabenhorst F., Parris B.A. Warm pleasant feelings in the brain // Neuroimage. 2008. Vol. 41, N 4. P. 1504–1513.

[42] Raison CL, Hale MW, Williams LE, et al. Somatic influences on subjective well·being and affective disorders: the convergence of thermosensory and central serotonergic systems. Front Psychol. 2015;5:1580. doi: 0.3389/fpsyg.2014.01580

[43] Raison C.L., Hale M.W., Williams L.E., et al. Somatic influences on subjective well·being and affective disorders: the convergence of thermosensory and central serotonergic systems // Front Psychol. 2015. N 5. P. 1580. doi: 10.3389/fpsyg.2014.01580

[44] Hale MW, Lowry CA. Functional topography of midbrain and pontine serotonergic systems: implications for synaptic regulation of serotonergic circuits. Psychopharmacology (Berl). 2011;213(2-3):243–264.

[45] Hale M.W., Lowry C.A. Functional topography of midbrain and pontine serotonergic systems: implications for synaptic regulation of serotonergic circuits // Psychopharmacology (Berl). 2011. Vol. 213, N 2–3. P. 243–264.

[46] Lowry CA, Hale MW, Evans AK, et al. Serotonergic systems, anxiety, and affective disorder: focus on the dorsomedial part of the dorsal raphe nucleus. Ann NY Acad Sci. 2008;1148:86–94.

[47] Lowry C.A., Hale M.W., Evans A.K., et al. Serotonergic systems, anxiety, and affective disorder: focus on the dorsomedial part of the dorsal raphe nucleus // Ann NY Acad Sci. 2008. Vol. 1148. P. 86–94.

[48] Robins HI, Kalin N, Shelton SE, et al. Rise in plasma beta-endorphin, ACTH, and cortisol in cancer patients undergoing whole body hyperthermia. Horm Metab Res. 1987;19:441–443. doi: 10.1055/s-2007-1011847

[49] Robins H.I., Kalin N., Shelton S.E., et al. Rise in plasma beta-endorphin, ACTH, and cortisol in cancer patients undergoing whole body hyperthermia // Horm Metab Res. 1987. Vol. 19. P. 441–443. doi: 10.1055/s-2007-1011847

[50] Hanusch KU, Janssen CH, Billheimer D, et al. Whole-body hyperthermia for the treatment of major depression: associations with thermoregulatory cooling. Am J Psychiatry. 2013;170(7):802–804.

[51] Hanusch K.U., Janssen C.H., Billheimer D., et al. Whole-body hyperthermia for the treatment of major depression: associations with thermoregulatory cooling // Am J Psychiatry. 2013. Vol. 170, N 7. P. 802–804.

[52] Jansen CW, Lowry CA, Mehl MR, et al. Whole-Body hyperthermia for the Treatment of Major Depressive Disorder. A Randomized Clinical Trial. JAMA Psychiatry. 2016;73(8):789–95. doi: 10.100l/jamapsychiatry.2016.1031

[53] Jansen C.W., Lowry C.A., Mehl M.R., et al. Whole-body hyperthermia for the treatment of major depressive disorder. A randomized clinical trial // JAMA Psychiatry. 2016. Vol. 73, N 8. P. 789–795. doi: 10.100l/jamapsychiatry.2016.1031

[54] Hanusch KU, Janssenb CW. The impact of whole-body hyperthermia interventions on mood and depression ― are we ready for recommendations for clinical application? Int J Hyperthermia. 2019;36(1):572–580. doi: 10.1080/02656736.2019.1612103

[55] Hanusch K.U., Janssenb C.W. The impact of whole-body hyperthermia interventions on mood and depression ― are we ready for recommendations for clinical application? // Int J Hyperthermia. 2019. Vol. 36, N 1. P. 572–580. doi: 10.1080/02656736.2019.1612103

[56] Kurpeshev O. Radiofrequency whole body hyperthermia (wbht) in cancer treatment. 28th annual meeting society for thermal medicine, New Orleans, USA; 2011. Abstract 0081.

[57] Kurpeshev O. Radiofrequency whole body hyperthermia (WBHT) in cancer treatment. 28th Annual Meeting Society for Thermal Medicine, New Orleans, USA, 2011. Abstract 0081.

[58] Balluzek FB, Balluzek MF, Vilensky VI. Controlled therapeutic hyperthermia. St. Petersburg; 2004. 248 p. (In Russ).

[59] Баллюзек Ф.Б., Баллюзек М.Ф., Виленский В.И. Контролируемая лечебная гипертермия. Санкт-Петербург: Росток, 2004. 248 с.

[60] Afari N, Buchwald D. Chronic fatigue syndrome: review. Am J Psychiatry 2003;160:221–236.

[61] Afari N., Buchwald D. Chronic fatigue syndrome: review // Am J Psychiatry. 2003. Vol. 160. P. 221–236.

[62] Soejima Y, Munemoto T, Masuda A, et al. Effects of Waon therapy on chronic fatigue syndrome: a pilot study. Intern Med. 2015;54(3):333–338. doi: 10.2169/internalmedicine.54.3042

[63] Soejima Y., Munemoto T., Masuda A., et al. Effects of waon therapy on chronic fatigue syndrome: a pilot study // Intern Med. 2015. Vol. 54, N 3. P. 333–338. doi: 10.2169/internalmedicine.54.3042

[64] Munemoto T, Soejima Y, Masuda A, et al. Increase in the regional cerebral blood flow following Waon therapy in patients with chronic fatigue syndrome: a pilot study. Intern Med. 2017;56:1817–1824. doi: 10.2169/internalmedicine.56.8001

[65] Munemoto T., Soejima Y., Masuda A., et al. Increase in the regional cerebral blood flow following waon therapy in patients with chronic fatigue syndrome: a pilot study // Intern Med. 2017. Vol. 56. P. 1817–1824. doi: 10.2169/internalmedicine.56.8001

[66] Boreham DR, Gasmann HC, Mitchel RE. Water bath hyperthermia is a simple therapy for psoriasis and also stimulates skin tanning in response to sunlight. Int J Hyperthermia. 1995;11(6):745–754. doi: 10.3109/02656739509052332

[67] Boreham D.R., Gasmann H.C., Mitchel R.E. Water bath hyperthermia is a simple therapy for psoriasis and also stimulates skin tanning in response to sunlight // Int J Hyperthermia. 1995. Vol. 11, N 6. P. 745–754. doi: 10.3109/02656739509052332

[68] Leviav A, Wolf R, Vilan A. Treatment of psoriasis with light and heat energy (LHE): a preliminary study. Dermatology Online Journal. 2004;10(2):4. doi: 10.5070/D33r84w3tx

[69] Leviav A., Wolf R., Vilan A. Treatment of psoriasis with light and heat energy (LHE): a preliminary study // Dermatol Online J. 2004. Vol. 10, N 2. P. 4. doi: 10.5070/D33r84w3tx

[70] Coleman W, Lowe N. Ultrasound-induced hyperthermia as adjuvant therapy for palmoplantar psoriasis. J Dermatolog Treatment. 2009;2(1):7–10. doi: 10.3109/09546639109089045

[71] Coleman W., Lowe N. Ultrasound-induced hyperthermia as adjuvant therapy for palmoplantar psoriasis // J Dermatological Treatment. 2009. Vol. 2, N 1. P. 7–10. doi: 10.3109/09546639109089045

[72] Krasnyak SS. Pathogenetic therapy of benign prostatic hyperplasia and prostatic intraepithelial neoplasia. Experimental and Clinical Urology. 2020;4:66–74. (In Russ). doi: 10.29188/2222-8543-2020-13-4-66-74

[73] Красняк С.С. Патогенетическая терапия доброкачественной гиперплазии предстательной железы и простатической интраэпителиальной неоплазии // Экспериментальная и клиническая урология. 2020. № 4. С. 66–74. doi: 10.29188/2222-8543-2020-13-4-66-74

[74] Kurpeshev OK, Konoplyannikov AG. Local electromagnetic hyperthermia of prostate adenoma. Medical radiology. 1991;36 (9):22–25. (In Russ).

[75] Курпешев О.К., Коноплянников А.Г. Локальная электромагнитная гипертермия аденомы предстательной железы // Медицинская радиология. 1991. Т. 36, № 9. С. 22–25.

[76] Yerushalmi A, Singer D, Katsnelson R, et al. Localised deep microwave hyperthermia in the treatment of benign prostatic hyperplasia: long-term assessment. Br J Urol. 1992;70(2):178–182.

[77] Yerushalmi A., Singer D., Katsnelson R., et al. Localised deep microwave hyperthermia in the treatment of benign prostatic hyperplasia: long-term assessment // Br J Urol. 1992. Vol. 70, N 2. P. 178–182.

[78] Apolikhin OI. Application of methods of hyperthermia, thermotherapy, thermal ablation in the treatment of benign prostatic hyperplasia [dissertation abstract]. Moscow; 1996. 52 p. (In Russ).

[79] Аполихин О.И. Применение методов гипертермии, термотерапии, термоаблации в лечении доброкачественной гиперплазии предстательной железы: Автореф. дис. … докт. мед. наук. Москва, 1996. 52 с.

[80] Brehmer M, Baba S. Transurethral microwave thermotherapy: how does it work? J Endourol. 2009;14(8):611–615. doi: 10.1089/end.2000.14.611

[81] Brehmer M., Baba S. Transurethral microwave thermotherapy: how does it work? // J Endourology. 2009. Vol. 14, N 8. P. 611–615. doi: 10.1089/end.2000.14.611

[82] Hoffman RM, Monga M, Elliott SP, et al. Microwave thermotherapy for benign prostatic hyperplasia. Cochrane Database Syst Rev. 2012;12(9):CD004135. doi: 10.1002/14651858.CD004135.pub3

[83] Hoffman R.M., Monga M., Elliott S.P., et al. Microwave thermotherapy for benign prostatic hyperplasia // Cochrane Database Syst Rev. 2012. Vol. 12, N 9. P. CD004135. doi: 10.1002/14651858.CD004135.pub3

[84] Sigel YI, Zaidel L, Linder A. The histopatology changes of beinign prostatic hyperplasia after hyperthermia treatment failure ― a controlled study. J Strahlenther Oncol. 1990;166(8):533.

[85] Sigel Y.I., Zaidel L., Linder A. The histopatology changes of beinign prostatic hyperplasia after hyperthermia treatment failure ― a controlled study // J Strahlenther Oncol. 1990. Vol. 166, N 8. P. 533.

[86] Kurpeshev OK, Tsyb AF, Mardynsky YuS. Transrectal electromagnetic hyperthermia of benign prostatic hyperplasia and chronic prostatitis. Guidelines. Obninsk; 2003. 21 p. (In Russ).

[87] Курпешев О.К., Цыб А.Ф., Мардынский Ю.С. Трансректальная электромагнитная гипертермия доброкачественной гиперплазии предстательной железы и хронического простатита. Методические рекомендации. Обнинск, 2003. 21 с.

[88] Barbalias GA, Liatsikos EN. Transrectal microwave hyperthermia for patients with benign prostatic hyperplasia. Int J Urol. 1998;5(2):157–162.

[89] Barbalias G.A., Liatsikos E.N. Transrectal microwave hyperthermia for patients with benign prostatic hyperplasia // Int J Urol. 1998. Vol. 5, N 2. P. 157–162.

[90] Perugia G, Liberti M, Vicini P, et al. Use of local hyperthermia as prophylaxis of fibrosis and modification in penile length following radical retropubic prostatectomy. Int J Hyperthermia. 2005;21(4):359–365.

[91] Perugia G., Liberti M., Vicini P., et al. Use of local hyperthermia as prophylaxis of fibrosis and modification in penile length following radical retropubic prostatectomy // Int J Hyperthermia. 2005. Vol. 21, N 4. P. 359–365.

[92] Borodin YI, Lyubarsky VV, Morozov MS. Guidelines for clinical lymphology. Moscow: МИА; 2010. 208 p. (In Russ).

[93] Бородин Ю.И., Любарский В.В., Морозов М.С. Руководство по клинической лимфологии. Москва: МИА, 2010. 208 с.

[94] Liu NF, Olszewski W. The influence of local hyperthermia on lymphedema and lymphedematous skin of the human leg. Lymphology. 1993;26(1):28–37.

[95] Liu N.F., Olszewski W. The influence of local hyperthermia on lymphedema and lymphedematous skin of the human leg // Lymphology. 1993. Vol. 26, N 1. P. 28–37.

[96] Campisi C, Boccardo F, Tacchella M. Use of thermotherapy in management of lymphedema: clinical observations. Int J Angiol. 1999;8(1):73–75. doi: 10.1007/BF01616849

[97] Campisi C., Boccardo F., Tacchella M. Use of thermotherapy in management of lymphedema: clinical observations // Int J Angiol 1999. Vol. 8, N 1. P. 73–75. doi: 10.1007/BF01616849

[98] Ohkuma M. Treatment of peripheral lymphoedema by concomitant application of magnetic fields, vibration and hyperthermia: a preliminary report. Lymphology. 2002;35:87–90.

[99] Ohkuma M. Treatment of peripheral lymphoedema by concomitant application of magnetic fields, vibration and hyperthermia: a preliminary report // Lymphology. 2002. Vol. 35. P. 87–90.

[100] Li K, Xu H, Liu NF, et al. Far-infrared ray for treating chronic lower extremity lymphedema with dermatolymphangioadenitis: a postoperative complication of gynecological tumor resection. Arch Gynecol Obstetrics. 2017. Ausgabe 6.

[101] Li K., Xu H., Liu N.F., et al. Far-infrared ray for treating chronic lower extremity lymphedema with dermatolymphangioadenitis: a postoperative complication of gynecological tumor resection // Arch Gynecol Obstetrics. 2017. Ausgabe 6.

[102] Li K, Zhang Z, Liu NF, et al. Far-infrared radiation thermotherapy improves tissue fibrosis in chronic extremity lymphedema. Lymphatic Research and Biology. 2018;16(3):248–257. doi: 10.1089/lrb.2016.0057

[103] Li K., Zhang Z., Liu N.F., et al. Far-infrared radiation thermotherapy improves tissue fibrosis in chronic extremity lymphedema. lymphatic research and biology. 2018. Vol. 16, N 3. P. 248–257. doi: 10.1089/lrb.2016.0057

[104] Kurpeshev OK. Radiobiological analysis of the development of early and late radiation injuries. Medical Radiology. 1984;29(3):54–64. (In Russ).

[105] Курпешев О.К. Радиобиологический анализ развития ранних и поздних лучевых повреждений // Медицинская радиология. 1984. Т. 29, № 3. С. 54–64.

[106] Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008;214:199–210.

[107] Wynn T.A. Cellular and molecular mechanisms of fibrosis // J Pathol. 2008. Vol. 214. P. 199–210.

[108] Yarnold J, Brotons MC. Pathogenetic mechanisms in radiation fibrosis. Radiother Oncol. 2010;97:149–161.

[109] Yarnold J., Brotons M.C. Pathogenetic mechanisms in radiation fibrosis // Radiother Oncol. 2010. Vol. 97. P. 149–161.

[110] Arankalayil MJ, Cohen EP, Wilkins RC, et al. Radiation-induced fibrosis: mechanisms and opportunities to mitigate. Report of an NCI workshop, September 19, 2016. Radiat Res. 2017;188:1–20.

[111] Arankalayil M.J., Cohen E.P., Wilkins R.C., et al. Radiation-induced fibrosis: mechanisms and opportunities to mitigate. Report of an NCI workshop, September 19, 2016 // Radiat Res. 2017. Vol. 188. P. 1–20.

[112] Kurpeshev OK, Pasov VV, Kurpesheva AK. Treatment of late radiation injuries using local radiofrequency hyperthermia. Medical Radiology and Radiation Safety. 2014;59(4):53–57. (In Russ).

[113] Курпешев О.К., Пасов В.В., Курпешева А.К. Лечение поздних лучевых повреждений с использованием локальной радиочастотной гипертермии // Медицинская радиология и радиационная безопасность. 2014. Т. 59, № 4. С. 53–57.

[114] Cassutti V, Ballerini M, Baronzio GH, Szasz O. AndroTherm application for Peyronie disease (Phase I/II study). Oncothermia J. 2012;5:11–22.

[115] Cassutti V., Ballerini M., Baronzio GH., Szasz O. AndroTherm application for peyronie disease (Phase I/II study) // Oncotherm J. 2012. N 5. P. 11–22.

[116] Ballerini M, Baronzio GH, Capito G, et al. AndroTherm application for "La Peyronie" disease. Oncothermia J. 2013;7:182–188.

[117] Ballerini M., Baronzio GH., Capito G., et al. AndroTherm application for "La Peyronie" disease // Oncotherm J. 2013. N 7. P. 182–188.

[118] Perugia G, Liberti M, Vicini P, et al. Role of hyperthermia in the treatment of Peyronie's disease: a preliminary study. Int J Hyperthermia. 2005;21(4):367–374. doi: 10.1080/02656730500133892

[119] Perugia G., Liberti M., Vicini P., et al. Role of hyperthermia in the treatment of Peyronie's disease: a preliminary study // Int J Hyperthermia. 2005. Vol. 21, N 4. P. 367–374. doi: 10.1080/02656730500133892

[120] Peyronie’s Disease: American Urological Association (AUA) Guideline (Panel Members). J Urol. 2015;194(3):745–753. doi: 10.1016/j.juro.2015.05.098

[121] Peyronie’s Disease: American Urological Association (AUA) Guideline (Panel Members) // J Urol. 2015. Vol. 194, N 3. P. 745–753. doi: 10.1016/j.juro.2015.05.098

[122] Cusmanich CC. Treatment of peyronie’s disease with hyperthermia, vitamin D and Testosterone: a pilot randomized controlled trial, running status, ethics approval: ethic committee of Hospital de Clinicas da Universidade Federal do Parana (Brazil), Curitiba, Brazil; 2007.

[123] Cusmanich C.C. Treatment of peyronie’s disease with hyperthermia, vitamin D and testosterone: a pilot randomized controlled trial, running status, ethics approval: ethic committee of Hospital de Clinicas da Universidade Federal do Parana (Brazil), Curitiba, Brazil, 2007.

[124] Biro S, Masuda A, Kihara T, Tei C. Clinical implications of thermal therapy in lifestyle-related diseases. Exp Biol Med. 2003;228(10):1245–1249.

[125] Biro S., Masuda A., Kihara T., Tei C. Clinical implications of thermal therapy in lifestyle-related diseases // Exp Biol Med. 2003. Vol. 228, N 10. P. 1245–1249.

[126] Kokura S, Adachi S, Mizushima K, et al. Gene expression profiles of diabetic mice treated with whole body hyperthermia: a high-density DNA microarray analysis. Int J Hyperthermia. 2010;26(2):101–107.

[127] Kokura S., Adachi S., Mizushima K., et al. Gene expression profiles of diabetic mice treated with whole body hyperthermia: a high-density DNA microarray analysis // Int J Hyperthermia. 2010. Vol. 26, N 2. P. 101–107.

[128] Sebők J, Édel Z, Váncsa S, et al. Heat therapy shows benefit in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Int J Hyperthermia. 2021;38(1):1650–1659. doi: 10.1080/02656736.2021.2003445

[129] Sebők J., Édel Z., Váncsa S., et al. Heat therapy shows benefit in patients with type 2 diabetes mellitus: a systematic review and meta-analysis // Int J Hyperthermia. 2021. Vol. 38, N 1. P. 1650–1659. doi: 10.1080/02656736.2021.2003445

[130] Oosterveld FG, Rasker JJ, Landkroon MF, et al. Infrared sauna in patients with rheumatoid arthritis and ankylosing spondylitis. Clin Rheumatol. 2009;28:29–34. doi: 10.1007/s10067-008-0977-y

[131] Oosterveld F.G., Rasker J.J., Landkroon M.F., et al. Infrared sauna in patients with rheumatoid arthritis and ankylosing spondylitis // Clin Rheumatol. 2009. Vol. 28. P. 29–34. doi: 10.1007/s10067-008-0977-y

[132] Lyon MS, Milligan C. Extracellular heat shock proteins in neurodegenerative diseases: new perspectives. Neuroscience Letters. 2019;711:134462. doi: 10.1016/j.neulet.2019.134462

[133] Lyon M.S., Milligan C. Extracellular heat shock proteins in neurodegenerative diseases: new perspectives // Neurosci Letters. 2019. Vol. 711. Р. 134462. doi: 10.1016/j.neulet.2019.134462

RIGHTS & PERMISSIONS

Eco-Vector